Omega Healthcare Investors (NYSE:OHI) Releases Quarterly Earnings Results, Beats Expectations By $0.33 EPS

Omega Healthcare Investors (NYSE:OHI) released its quarterly earnings data on Wednesday. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.33, Zacks reports. Omega Healthcare Investors had a return on equity of 8.83% and a net margin of 34.41%. Omega Healthcare Investors updated its FY 2025 guidance to 2.900-2.980 EPS.

Omega Healthcare Investors Stock Performance

Shares of NYSE OHI traded up $0.73 during trading hours on Wednesday, reaching $38.33. The stock had a trading volume of 2,807,746 shares, compared to its average volume of 1,855,654. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The business’s fifty day moving average is $38.16 and its two-hundred day moving average is $39.08. Omega Healthcare Investors has a twelve month low of $27.74 and a twelve month high of $44.42. The company has a market cap of $10.35 billion, a price-to-earnings ratio of 28.18, a PEG ratio of 1.08 and a beta of 0.99.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Monday, February 10th will be given a $0.67 dividend. The ex-dividend date is Monday, February 10th. This represents a $2.68 annualized dividend and a yield of 6.99%. Omega Healthcare Investors’s dividend payout ratio is 197.06%.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target for the company in a research note on Thursday, October 31st. Mizuho boosted their target price on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research report on Thursday, December 5th. Berenberg Bank started coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 price target on the stock. Royal Bank of Canada upped their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a report on Monday, November 11th. Finally, BMO Capital Markets raised Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price target for the company in a research report on Monday, December 9th. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors currently has a consensus rating of “Moderate Buy” and a consensus target price of $41.67.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.